🇺🇸 FDA
Patent

US 7563596

Method of modulating tissue growth using Frzb protein

granted A61KA61K38/00A61K48/00

Quick answer

US patent 7563596 (Method of modulating tissue growth using Frzb protein) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K48/00